TY - JOUR
T1 - Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V)
T2 - a randomised non-inferiority trial
AU - Christiansen, Evald Høj
AU - Jensen, Lisette Okkels
AU - Thayssen, Per
AU - Tilsted, Hans-Henrik
AU - Krusell, Lars Romer
AU - Hansen, Knud Nørregaard
AU - Kaltoft, Anne Kjer
AU - Maeng, Michael
AU - Kristensen, Steen Dalby
AU - Bøtker, Hans Erik
AU - Terkelsen, Christian Juhl
AU - Villadsen, Anton Boel
AU - Ravkilde, Jan
AU - Aarøe, Jens
AU - Madsen, Morten
AU - Thuesen, Leif
AU - Lassen, Jens Flensted
AU - Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) V investigators
N1 - Copyright © 2013 Elsevier Ltd. All rights reserved.
PY - 2013/2/23
Y1 - 2013/2/23
N2 - Third-generation biodegradable polymer drug-eluting stents might reduce the risk of stent thrombosis compared with first-generation permanent polymer drug-eluting stents. We aimed to further investigate the effects of a biodegradable polymer biolimus-eluting stent compared with a durable polymer-coated sirolimus-eluting stent in a population-based setting.
AB - Third-generation biodegradable polymer drug-eluting stents might reduce the risk of stent thrombosis compared with first-generation permanent polymer drug-eluting stents. We aimed to further investigate the effects of a biodegradable polymer biolimus-eluting stent compared with a durable polymer-coated sirolimus-eluting stent in a population-based setting.
KW - Absorbable Implants
KW - Acute Coronary Syndrome
KW - Aged
KW - Aspirin
KW - Coated Materials, Biocompatible
KW - Coronary Artery Disease
KW - Coronary Thrombosis
KW - Drug-Eluting Stents
KW - Female
KW - Humans
KW - Male
KW - Myocardial Infarction
KW - Percutaneous Coronary Intervention
KW - Platelet Aggregation Inhibitors
KW - Polymers
KW - Retreatment
KW - Sirolimus
U2 - 10.1016/S0140-6736(12)61962-X
DO - 10.1016/S0140-6736(12)61962-X
M3 - Journal article
C2 - 23374649
SN - 0140-6736
VL - 381
SP - 661
EP - 669
JO - Lancet
JF - Lancet
IS - 9867
ER -